Account
Inquiry
Amble Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This compound demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.
The molecular structure of Amble Tirzepatide allows for balanced activation of both GIP and GLP-1 receptors, with preferential binding to GIP receptors. This unique pharmacological profile contributes to its enhanced metabolic effects in research settings.
Our Amble Tirzepatide is supplied as a white to off-white powder with purity exceeding 98% by HPLC analysis. The product is carefully packaged to ensure stability and is intended for research purposes only.
Storage conditions recommend keeping the product at 2-8°C for short-term use or -20°C for long-term preservation. Proper handling procedures should be followed as with all research compounds.
As a manufacturer, we specialize in providing high-quality peptide compounds for research institutions and pharmaceutical development. Our Amble Tirzepatide is produced under strict quality control measures to ensure batch-to-batch consistency.
This product is for research use only and not intended for human consumption. Researchers should follow all applicable regulations and safety protocols when handling this material.
